DUSP9
Dual specificity protein phosphatase 9
Also known as: DUS9_HUMAN, MKP-4, MKP4
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q99956
- Gene
- DUSP9
- Ensembl
- ENSG00000130829
- Chromosome
- X
- Canonical length
- 384 aa
- Protein class
- Enzymes, Predicted intracellular proteins
- Subcellular location
- Endoplasmic reticulum
OverviewNCBI Gene
The protein encoded by this gene is a member of the dual specificity protein phosphatase subfamily. These phosphatases inactivate their target kinases by dephosphorylating both the phosphoserine/threonine and phosphotyrosine residues. They negatively regulate members of the mitogen-activated protein (MAP) kinase superfamily (MAPK/ERK, SAPK/JNK, p38), which is associated with cellular proliferation and differentiation. Different members of the family of dual specificity phosphatases show distinct substrate specificities for various MAP kinases, different tissue distribution and subcellular localization, and different modes of inducibility of their expression by extracellular stimuli. This gene product shows selectivity for members of the ERK family of MAP kinases and is localized to the cytoplasm and nucleus. Aberrant expression of this gene is associated with type 2 diabetes and cancer progression in several cell types. Alternate splicing results in multiple transcript variants. [provided by RefSeq, Jan 2016]
Canonical amino-acid sequenceUniProt
384 residues, UniProt reviewed canonical sequence.
>Q99956|DUSP9
1 MEGLGRSCLW LRRELSPPRP RLLLLDCRSR ELYESARIGG ALSVALPALL LRRLRRGSLS
61 VRALLPGPPL QPPPPAPVLL YDQGGGRRRR GEAEAEAEEW EAESVLGTLL QKLREEGYLA
121 YYLQGGFSRF QAECPHLCET SLAGRAGSSM APVPGPVPVV GLGSLCLGSD CSDAESEADR
181 DSMSCGLDSE GATPPPVGLR ASFPVQILPN LYLGSARDSA NLESLAKLGI RYILNVTPNL
241 PNFFEKNGDF HYKQIPISDH WSQNLSRFFP EAIEFIDEAL SQNCGVLVHC LAGVSRSVTV
301 TVAYLMQKLH LSLNDAYDLV KRKKSNISPN FNFMGQLLDF ERSLRLEERH SQEQGSGGQA
361 SAASNPPSFF TTPTSDGAFE LAPTLocalizationUniProt · AlphaFold · HPA
Whether an antibody against DUSP9 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Intracellular
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.39
- Highest tissue expression
- 68 nTPM
Expression across tissuesHPA
Tissue
- placenta: 68 nTPM
- kidney: 52 nTPM
- basal ganglia: 5.3 nTPM
- amygdala: 4.1 nTPM
- hippocampal formation: 3.4 nTPM
- cerebral cortex: 2.8 nTPM
Single-cell type
- syncytiotrophoblasts: 1,984 nCPM
- cytotrophoblasts: 1,518 nCPM
- migrating cytotrophoblasts: 546 nCPM
- extravillous trophoblasts: 45 nCPM
- distal convoluted tubule cells: 42 nCPM
- loop of henle epithelial cells: 30 nCPM
Immune cell
- basophil: 0 nTPM
- classical monocyte: 0 nTPM
- eosinophil: 0 nTPM
- gdT-cell: 0 nTPM
- intermediate monocyte: 0 nTPM
- MAIT T-cell: 0 nTPM
Brain region
- amygdala: 6.3 nTPM
- hippocampal formation: 6.1 nTPM
- cerebral cortex: 5.7 nTPM
- basal ganglia: 4.7 nTPM
- thalamus: 3.5 nTPM
- white matter: 3.2 nTPM
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.53
- gnomAD pLI
- 0.82
- gnomAD missense Z
- 1.32
- DepMap mean gene effect
- -0.04
- DepMap dependency class
- none
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 5% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- ERK1 and ERK2 cascade
- JNK cascade
- MAPK cascade
- negative regulation of ERK1 and ERK2 cascade
- protein dephosphorylation
- signal transduction
Molecular functions
- MAP kinase tyrosine phosphatase activity
- MAP kinase tyrosine/serine/threonine phosphatase activity
- phosphoprotein phosphatase activity
- protein serine/threonine phosphatase activity
- protein tyrosine/serine/threonine phosphatase activity
- protein tyrosine/threonine phosphatase activity
Cellular components
Protein domainsUniProt · Pfam · InterPro
- Dual specificity phosphatase, catalytic domain
- Tyrosine-specific protein phosphatases domain
- Rhodanese-like domain
- Mitogen-activated protein (MAP) kinase phosphatase
- Dual specificity protein phosphatase domain
- Protein-tyrosine phosphatase-like
- Rhodanese-like domain superfamily
- Rhodanese-like domain
- Dual specificity phosphatase, catalytic domain
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of DUSP9 in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads DUSP9 as an antibody target. Whether an autoantibody or antibody against DUSP9 could matter depends on whether native DUSP9 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
DUSP9 is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label DUSP9 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...